1. Home
  2. MIST vs ORGN Comparison

MIST vs ORGN Comparison

Compare MIST & ORGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • ORGN
  • Stock Information
  • Founded
  • MIST 2003
  • ORGN 2008
  • Country
  • MIST Canada
  • ORGN United States
  • Employees
  • MIST N/A
  • ORGN N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • ORGN Major Chemicals
  • Sector
  • MIST Health Care
  • ORGN Industrials
  • Exchange
  • MIST Nasdaq
  • ORGN Nasdaq
  • Market Cap
  • MIST 89.8M
  • ORGN 72.7M
  • IPO Year
  • MIST N/A
  • ORGN N/A
  • Fundamental
  • Price
  • MIST $1.71
  • ORGN $0.43
  • Analyst Decision
  • MIST Strong Buy
  • ORGN Strong Buy
  • Analyst Count
  • MIST 2
  • ORGN 1
  • Target Price
  • MIST $7.50
  • ORGN $3.00
  • AVG Volume (30 Days)
  • MIST 658.4K
  • ORGN 818.7K
  • Earning Date
  • MIST 08-07-2025
  • ORGN 08-13-2025
  • Dividend Yield
  • MIST N/A
  • ORGN N/A
  • EPS Growth
  • MIST N/A
  • ORGN N/A
  • EPS
  • MIST N/A
  • ORGN N/A
  • Revenue
  • MIST N/A
  • ORGN $29,887,000.00
  • Revenue This Year
  • MIST N/A
  • ORGN $49.18
  • Revenue Next Year
  • MIST N/A
  • ORGN $144.81
  • P/E Ratio
  • MIST N/A
  • ORGN N/A
  • Revenue Growth
  • MIST N/A
  • ORGN N/A
  • 52 Week Low
  • MIST $0.63
  • ORGN $0.40
  • 52 Week High
  • MIST $2.75
  • ORGN $1.90
  • Technical
  • Relative Strength Index (RSI)
  • MIST 60.15
  • ORGN 38.07
  • Support Level
  • MIST $1.67
  • ORGN $0.42
  • Resistance Level
  • MIST $1.80
  • ORGN $0.47
  • Average True Range (ATR)
  • MIST 0.08
  • ORGN 0.03
  • MACD
  • MIST -0.01
  • ORGN 0.01
  • Stochastic Oscillator
  • MIST 43.24
  • ORGN 24.20

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About ORGN Origin Materials Inc.

Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.

Share on Social Networks: